The US Food and Drug Administration (FDA) has released over 200 letters it sent to companies that rejected their medicines. The move aims to increase transparency in the drug review process. Previously, only approved medicines’ rejections were made public. Redacted portions protect private business details. This is the first time many of these letters have been published, with at least 14 making their debut.
Source: https://www.statnews.com/2025/07/10/fda-publishes-drug-rejection-letters-marty-makary-transparency-effort